These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8969321)

  • 1. What you don't know can't hurt you? Statistical issues and standards for medical technology evaluation.
    Mullahy J
    Med Care; 1996 Dec; 34(12 Suppl):DS124-35. PubMed ID: 8969321
    [No Abstract]   [Full Text] [Related]  

  • 2. Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
    von der Schulenburg J; Vauth C; Mittendorf T; Greiner W
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S5-31. PubMed ID: 17582539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of the economic evaluation of health technologies. European developments.
    Rovira J
    Med Care; 1996 Dec; 34(12 Suppl):DS182-8. PubMed ID: 8969325
    [No Abstract]   [Full Text] [Related]  

  • 4. What you don't know can't hurt you. . .
    Caplan M
    Physiology (Bethesda); 2008 Apr; 23():60. PubMed ID: 18400688
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical comments.
    Kikushi T
    Value Health; 2008; 11(2):345; discussion 346. PubMed ID: 18380647
    [No Abstract]   [Full Text] [Related]  

  • 6. MRI: when you can't afford not to.
    Cushmore FN; Kucharczyk W; Rodibaugh DL
    Patient Care; 1989 Feb; 23(4):26-30, 32-4, 36 passim. PubMed ID: 10312902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical electronics: buy now.
    European Coordination Committee of Radiological and Electromedical Manufacturers
    Med Device Technol; 2003 Jun; 14(5):37. PubMed ID: 12852124
    [No Abstract]   [Full Text] [Related]  

  • 8. Community based rehabilitation programmes: monitoring and evaluation in order to measure results.
    Cornielje H; Velema JP; Finkenflügel H
    Lepr Rev; 2008 Mar; 79(1):36-49. PubMed ID: 18540236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation for pharmaceuticals in Germany.
    Jönsson B
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
    [No Abstract]   [Full Text] [Related]  

  • 10. Transparency of economic evaluations of health technologies.
    Rovira J
    Pharmacoeconomics; 2008; 26(3):181-3. PubMed ID: 18282013
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining types of economic evaluation.
    Ngorsuraches S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of costs.
    Riewpaiboon A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S28-37. PubMed ID: 19253485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: What you don't add can't hurt you.
    Lundie P
    Dent J; 1975 Mar; 41(3):124. PubMed ID: 1054684
    [No Abstract]   [Full Text] [Related]  

  • 14. Double counting and the reporting of cost per event avoided.
    Mullins CD
    Clin Ther; 2006 Apr; 28(4):602-3. PubMed ID: 16750471
    [No Abstract]   [Full Text] [Related]  

  • 15. What high tech can't accomplish: beyond the Clinton plan.
    Cowley G
    Newsweek; 1993 Oct; 122(14):60-3. PubMed ID: 10129603
    [No Abstract]   [Full Text] [Related]  

  • 16. Statistical analysis in pharmacoeconomic studies. A review of current issues and standards.
    Coyle D
    Pharmacoeconomics; 1996 Jun; 9(6):506-16. PubMed ID: 10160478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where does high-quality research in economic evaluation come from?
    Zhang JX
    Pharmacotherapy; 2009 Jan; 29(1):1-2. PubMed ID: 19113791
    [No Abstract]   [Full Text] [Related]  

  • 18. Regarding probabilistic analysis and computationally expensive models: necessary and required?
    Caro JJ; Getsios D; Möller J
    Value Health; 2007; 10(4):317-8; author reply 319. PubMed ID: 17645686
    [No Abstract]   [Full Text] [Related]  

  • 19. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.
    Claxton K; Sculpher M; McCabe C; Briggs A; Akehurst R; Buxton M; Brazier J; O'Hagan T
    Health Econ; 2005 Apr; 14(4):339-47. PubMed ID: 15736142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient satisfaction: what you see is what you get. You can't improve it unless you know what patients think.
    Ganey RF; Drain M
    Trustee; 1998; 51(10):6-10. PubMed ID: 10186426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.